Arrhythmia Disorders News

Driving restrictions after implantable cardioverter defibrillator implantation negatively affected patient daily living, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.

Pulmonary vein isolation was associated with genuine improvements in patients with atrial fibrillation at 6 months that cannot be attributed to a placebo effect, researchers reported at the European Society of Cardiology Congress.

Edoxaban monotherapy for patients with atrial fibrillation and stable coronary disease reduced risk for adverse clinical events, mainly driven by lower bleeding risk, compared with dual antiplatelet therapy, a speaker reported.

Treatment of atrial fibrillation with asundexian, a novel factor XIa inhibitor, was associated with increased stroke and systemic embolism risk despite lower bleeding risk compared with apixaban, a speaker reported.

Among patients who had cardiac surgery, men were more likely than women to have postoperative atrial fibrillation, but for those with postoperative AF, the mortality risk was greater in women, researchers reported.

Defibtech has issued a recall of its automated continuous chest compression device due to risk for the device to halt compressions during use.

Exposure of certain cardiac structures to radiation during treatment of surgically inoperable or unresectable non-small cell lung cancer was associated with increased arrhythmia risk, researchers reported.

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.

Job strain and effort-reward imbalance in the workplace may put white-collar workers at increased risk for experiencing a heart arrhythmia, researchers reported.

The Care of the Athletic Heart Conference, held at Heart House in Washington, D.C., in early June, covered the entire scope of sports cardiology, with sessions tailored to new and seasoned sports cardiologists.